Evidence map›Paper›PMID 42883984›Full record

ArticleInternational journal of molecular sciences2026

Untargeted Serum Metabolomics Reveals Metabolic Disturbances in Children with MASLD: A Preliminary Study.

Ewa Kowalska-Ciszek, Julia Zelkowska, Wojciech Jańczyk, Katarzyna Patla, Anna Siejka, Joanna Klimiuk-Balas, Magdalena Zielińska, Anna Świąder-Leśniak, Joanna Godzien, Dominik Cysewski and 4 more

Abstract read
In one paragraph

Article in International journal of molecular sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Ewa Kowalska-CiszekDepartment of Clinical Biochemistry, The Children's Memorial Health Institute, 04-730 Warsaw, Poland.ORCID 0000-0002-0681-3075
Julia ZelkowskaMetabolomics and Proteomics Laboratory, Clinical Research Centre, Medical University of Bialystok, 15-276 Bialystok, Poland.ORCID 0000-0002-4340-0085
Wojciech JańczykDepartment of Gastroenterology, Hepatology and Nutrition Disorders, The Children's Memorial Health Institute, 04-730 Warsaw, Poland.ORCID 0000-0002-6430-0788
Katarzyna PatlaDepartment of Clinical Biochemistry, The Children's Memorial Health Institute, 04-730 Warsaw, Poland.
Anna SiejkaDepartment of Clinical Biochemistry, The Children's Memorial Health Institute, 04-730 Warsaw, Poland.
Joanna Klimiuk-BalasDepartment of Clinical Biochemistry, The Children's Memorial Health Institute, 04-730 Warsaw, Poland.
Magdalena ZielińskaDepartment of Clinical Biochemistry, The Children's Memorial Health Institute, 04-730 Warsaw, Poland.
Anna Świąder-LeśniakDepartment of Anthropology, The Children's Memorial Health Institute, 04-730 Warsaw, Poland.ORCID 0000-0001-5935-4442
Joanna GodzienMetabolomics and Proteomics Laboratory, Clinical Research Centre, Medical University of Bialystok, 15-276 Bialystok, Poland.ORCID 0000-0002-9477-057X
Dominik CysewskiMetabolomics and Proteomics Laboratory, Clinical Research Centre, Medical University of Bialystok, 15-276 Bialystok, Poland.ORCID 0000-0001-6206-0672
Agnieszka OchocińskaDepartment of Clinical Biochemistry, The Children's Memorial Health Institute, 04-730 Warsaw, Poland.ORCID 0000-0002-6997-6197
Mieczysław LitwinDepartment of Nephrology and Arterial Hypertension, The Children's Memorial Health Institute, 04-730 Warsaw, Poland.ORCID 0000-0002-5241-2483
Michał CiborowskiMetabolomics and Proteomics Laboratory, Clinical Research Centre, Medical University of Bialystok, 15-276 Bialystok, Poland.ORCID 0000-0003-3729-0518
Piotr SochaDepartment of Gastroenterology, Hepatology and Nutrition Disorders, The Children's Memorial Health Institute, 04-730 Warsaw, Poland.

Funding

Children's Memorial Health Institute M24/2017Children's Memorial Health Institute S178/2018
6 · The paper itself

Abstract

Pediatric metabolic dysfunction-associated steatotic liver disease (MASLD) has emerged as a major public health concern. The pediatric form of MASLD differs from the adult phenotype in its pathophysiology and exhibits distinct histopathological characteristics. This study aimed to characterize serum metabolomic alterations associated with pediatric MASLD and to identify metabolic signatures that may provide further insight into the disease phenotype. To this end, untargeted metabolomic analysis was performed on serum samples from 21 pediatric MASLD patients and 22 healthy controls using liquid chromatography coupled with high-resolution quadrupole time-of-flight mass spectrometry (LC-MS/QTOF). Univariate statistical analysis was performed using the Mann-Whitney U-test with false discovery rate (FDR) correction, while multivariate analysis employed principal component analysis and orthogonal partial least squares discriminant analysis (OPLS-DA). Multivariate analysis in the positive ionization mode demonstrated clear separation between the MASLD and control groups (R

Indexed as

Fatty LiverMetabolomeMetabolomicsAdolescentBile Acids and SaltsBiomarkersChildChild, PreschoolFemaleHumansMaleBile Acids and SaltsBiomarkers12α-hydroxy-3-oxocholadienic acidacylcarnitinebile acid metabolismpediatric MASLDuntargeted metabolomics

Identifiers

PMID42883984
PMCPMC13664932

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.